21:00 EST 21st January 2019 | BioPortfolio



San Martín 137
Buenos Aires
Buenos Aires


Phone: 054 (011) 4347-0000

News Articles [11 Associated News Articles listed on BioPortfolio]

Banco Macro Announces Results for the Second Quarter of 2018

BUENOS AIRES, Argentina, Aug. 22, 2018 /PRNewswire/ -- Banco Macro S.A. (NYSE: BMA; BCBA: BMA) ("Banco Macro" or "BMA" or the "Bank") announced today its Read more...

95ª Reunião do G100 Brasil

SÃO PAULO, 14 de setembro de 2018 /PRNewswire/ -- A menos de um mês do primeiro turno das eleições presidenciais, o economista-chefe do Banco Votorantim, Read more...

Sterlite Power anuncia el cierre financiero del proyecto Arcoverde

SAO PAULO, 24 de diciembre de 2018 /PRNewswire/ -- BTG, Santander será el banco líder del proyecto Las actividades de construcción se están ejecutando con Read more...

Banco Bradesco Results in the 2nd Quarter of 2018

SAO PAULO, July 26, 2018 /PRNewswire/ -- The main figures obtained by Bradesco (B3: BBDC3, BBDC4; NYSE: BBD and Latibex: XBBDC) are presented below: Recurring Read more...

Banco Bradesco-Ergebnisse für das 2. Quartal 2018

SAO PAULO, 27. Juli 2018 /PRNewswire/ -- Die wichtigsten Zahlen von Bradesco (B3: BBDC3, BBDC4; NYSE: BBD und Latibex: XBBDC) werden nachfolgend aufgeführt: Das bereinigte Read more...

LAFIS: Com baixa inflação em dezembro, IPCA fecha abaixo do centro da meta do Banco Central

SAO PAULO, 11 de janeiro de 2019 /PRNewswire/ -- De acordo com a divulgação feita pelo IBGE nesta sexta-feira (11/01), o IPCA variou 0,15% no Read more...

Resultados del tercer trimestre de 2018 de Banco Bradesco

SÃO PAULO, 2 de noviembre de 2018 /PRNewswire/ -- Los principales resultados comunicados por Bradesco se muestran a continuación: 1. Los ingresos netos recurrentes del Read more...

Résultats de Banco Bradesco au deuxième trimestre 2018

SAO PAULO, 27 juillet 2018 /PRNewswire/ -- Les principaux résultats obtenus par Bradesco (B3 : BBDC3, BBDC4 ; NYSE : BBD et Latibex : XBBDC) Read more...

Drugs and Medications [0 Results]


Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

BANCO Study: Behavioral Addictions and Related NeuroCOgnitive Aspects: A Monocentric, Prospective, Controlled, Open-label Study of a Sample of Patients With Gambling Disorder

The prevalence of people suffering from gambling disorder is relatively high, and the impact on this disorder the individual and those around him is considerable. The etiopathogenic model ...

Companies [5 Associated Companies listed on BioPortfolio]



Santander UK

Banco Santander (SAN.MC, STD.N, BNC.LN) is a retail and commercial bank, based in Spain, with presence in 10 main markets. Services include personal banking, insurance and mortgages. At the close of J...

Virtual Hold Technology

Virtual Hold Technology (VHT) is the leading developer of virtual queuing solutions for Fortune 1000 clients. Since its inception in 1995, VHT's patented, award-winning virtual queuing technology ...

Grupo Salinas

Grupo Salinas ( is a group of dynamic, fast-growing and technologically advanced companies focused on creating shareholder value, contributing to building the middle class of the ...


ABN AMRO is one of the leading investment and corporate banks in Sweden, as well as a leading asset manager. While committed to building long-term relationships, we deliver customised products and ser...

More Information about "BANCO PROVINCIA" on BioPortfolio

We have published hundreds of BANCO PROVINCIA news stories on BioPortfolio along with dozens of BANCO PROVINCIA Clinical Trials and PubMed Articles about BANCO PROVINCIA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BANCO PROVINCIA Companies in our database. You can also find out about relevant BANCO PROVINCIA Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record